Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New tripolar EEG could spot seizures faster and more comfortably

NCT ID NCT05944692

Diagnosis Sponsor: CREmedical Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing a new type of EEG device called tripolar EEG (tEEG) to see if it can detect seizures in people with epilepsy better than the standard EEG. Researchers will compare recordings from both devices in 90 adults and children. The goal is to see if tEEG reduces interference and helps doctors identify seizure activity more accurately.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
tripolar electroencephalography (tEEG) device
What this could lead to
If successful, this could lead to a more accurate and comfortable way to detect seizures, improving epilepsy diagnosis.
What could go wrong
This is an early-stage study with only 90 participants, so results may not apply to everyone. The new device might not be significantly better than standard EEG.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 90 people

The number the study aims to enrol. It can still change while the study runs.

Started

Sep 2025

Expected to finish

Aug 2026

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Pediatric and adult patients either suspected of, or having epilepsy.

Ages

6 years and older

Sex

Anyone

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Pediatric (BCH): Age ≥ 6 years and \< 18 years * Adult (BNI): Age ≥ 18 years * Able to provide written informed consent or have a legally authorized representative able to provide consent; pediatric patients to provide assent when appropriate * Scheduled for routine outpatient EEG for clinical diagnosis * Able to participate in a post-EEG telemedicine video visit * Clinical diagnosis of epilepsy with epileptiform discharges on prior routine EEG * Scheduled for inpatient video-EEG monitoring for clinical diagnosis * MRI of brain available for co-registration * Confirmed diagnosis of focal epilepsy by prior video-EEG monitoring interpreted by board-certified epileptologist or clinical neurophysiologist * Scheduled for inpatient video-EEG monitoring with intracranial stereo-EEG electrodes for epilepsy presurgical evaluation * MRI of brain available for co-registration Exclusion criteria * Presence of a condition or abnormality that in the opinion of the Investigator would compromise the safety of the subject or the integrity of the data * Any clinical suspicion of prion disease * History of allergy or adverse reaction to EEG electrode paste or gel * Scalp lesions or infections * Severe intellectual disability or behavioral disorders with inability to cooperate with EEG application or recording

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Epilepsy are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

epilepsy focal epilepsy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Epilepsy

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    2 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Barrow Neurological Institute Dignity Health dba St. Joseph's Hospital and Medical Center

    RECRUITING

    Phoenix, Arizona, 85013, United States

  • Boston Children's Hospital

    RECRUITING

    Boston, Massachusetts, 02115, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.